NFKB1 and cancer: It has also long been known that mutant RAS proteins activate the nuclear factor of kappa light polypeptide gene enhancer of the B-cells (NF-κB) pathway in cancer cells (Cullis et al., 2018; Finco et al., 1997; Kim et al., 2002).